Beijing Tri Prime Gene Pharmaceutical Co (BJSE:920344) Short Ratio

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BJSE:920344 Beijing Tri Prime Gene Pharmaceutical Co Ltd BJSE:920344
83 GF Score
Price ¥18.90
GF Value ¥20.89
Valuation Modestly Undervalued
! 7 Warning Signs
View Full Analysis

What is Beijing Tri Prime Gene Pharmaceutical Co Short Ratio?

Short Ratio is a metric signaling prevailing investors' sentiment with a company. It represents the number of days it takes short sellers on average to repurchase all the shares short.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

BJSE:920344
83GF Score
Beijing Tri Prime Gene Pharmaceutical Co Ltd BJSE:920344
Short Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Beijing Tri Prime Gene Pharmaceutical Co (BJSE:920344) Overvalued in 2026?

Based on GuruFocus' analysis, Beijing Tri Prime Gene Pharmaceutical Co stock appears to be undervalued. The current stock price of ¥18.90 is trading 9.5% below its estimated GF Value™ of ¥20.89. GuruFocus considers Beijing Tri Prime Gene Pharmaceutical Co to be Modestly Undervalued.

Key valuation signals for BJSE:920344:

  • Short Ratio:
  • GF Value™: ¥20.89 vs. price of ¥18.90 (9.5% below fair value)
  • GF Score™: 83/100 with 7 warning signs

No single metric tells the full story. See the BJSE:920344 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Beijing Tri Prime Gene Pharmaceutical Co Business Description

Address No. 20, Jinghong Street, Biomedicine Base, Daxing District, Beijing, CHN, 102600
Beijing Tri Prime Gene Pharmaceutical Co Ltd is mainly engaged in the research, development, production, and sales of medical biotechnology products, including genetic engineering drugs, genetic engineering vaccines, and diagnostic reagents, and is engaged in related technical trade and technical consulting services. Its product line comprises Yundex Spray, Yundex Eye Drops, Yundexol Powder Injection, and Yundexol Water Injection.
83GF Score

Get the complete analysis for BJSE:920344

Short Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥18.90
Price
¥20.89
GF Value